AU499475B2 - Anti-malignant tumor composition - Google Patents

Anti-malignant tumor composition

Info

Publication number
AU499475B2
AU499475B2 AU23073/77A AU2307377A AU499475B2 AU 499475 B2 AU499475 B2 AU 499475B2 AU 23073/77 A AU23073/77 A AU 23073/77A AU 2307377 A AU2307377 A AU 2307377A AU 499475 B2 AU499475 B2 AU 499475B2
Authority
AU
Australia
Prior art keywords
malignant tumor
tumor composition
composition
malignant
tumor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU23073/77A
Other languages
English (en)
Other versions
AU2307377A (en
Inventor
Takeuchi & Mitsuyuki Kiichi Setsuo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RIKEN
Original Assignee
RIKEN
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by RIKEN filed Critical RIKEN
Publication of AU2307377A publication Critical patent/AU2307377A/en
Application granted granted Critical
Publication of AU499475B2 publication Critical patent/AU499475B2/en
Expired legal-status Critical Current

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/11—Aldehydes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nanotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU23073/77A 1976-03-09 1977-03-09 Anti-malignant tumor composition Expired AU499475B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JPJP25225/76 1976-03-09
JP2522576A JPS52108027A (en) 1976-03-09 1976-03-09 Anticarcinogen

Publications (2)

Publication Number Publication Date
AU2307377A AU2307377A (en) 1978-09-14
AU499475B2 true AU499475B2 (en) 1979-04-26

Family

ID=12160014

Family Applications (1)

Application Number Title Priority Date Filing Date
AU23073/77A Expired AU499475B2 (en) 1976-03-09 1977-03-09 Anti-malignant tumor composition

Country Status (9)

Country Link
US (1) US4983636A (en:Method)
JP (1) JPS52108027A (en:Method)
AU (1) AU499475B2 (en:Method)
BE (1) BE852283A (en:Method)
CA (1) CA1093971A (en:Method)
DE (1) DE2710327C3 (en:Method)
FR (1) FR2343475A1 (en:Method)
GB (1) GB1573965A (en:Method)
NL (1) NL172917C (en:Method)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5446001U (en:Method) * 1977-09-07 1979-03-30
JPS5830032B2 (ja) * 1981-02-18 1983-06-27 呉羽化学工業株式会社 ビフイダス菌の増殖剤
JPS6112623A (ja) * 1984-06-28 1986-01-21 Kaken Pharmaceut Co Ltd エンケフアリナ−ゼ阻害剤
JPS6256423A (ja) * 1985-09-06 1987-03-12 Kaken Pharmaceut Co Ltd 悪液質治療改善剤
GB8705780D0 (en) * 1987-03-11 1987-04-15 Norsk Hydro As Anticancer compounds
AT393221B (de) * 1988-02-03 1991-09-10 Leopold Pharma Gmbh Mittel mit zerstoerender wirkung auf maligne tumore, verfahren zu dessen herstellung und praeparation zur anwendung in der therapie von krebskranken
JPH0269540A (ja) * 1988-09-05 1990-03-08 Chisso Corp 結晶性ポリオレフイン組成物
US5330744A (en) * 1988-11-14 1994-07-19 Sloan-Kettering Institute For Cancer Research Method for increasing sensitivity to chemically induced terminal differentiation
US5180716A (en) * 1990-08-01 1993-01-19 The Regents Of The University Of California Cyclodextrin complexes for neuraxial administration of drugs
US5789189A (en) * 1993-09-24 1998-08-04 The Regents Of The University Of California Inhibition of cyst formation by cytoskeletal specific drugs
GB2298791B (en) * 1995-03-13 1999-05-05 Stepan Co Methods and compositions for disinfecting surfaces containing tuberculosis causing bacteria
EA007649B1 (ru) * 1999-09-08 2006-12-29 Слоан-Кеттеринг Инститьют Фор Кэнсер Рисёч Ингибиторы гистондеацетилазы, вызывающие дифференцировку клеток, и их применение
TWI242015B (en) 1999-11-29 2005-10-21 Akzo Nobel Nv 6-mercapto-cyclodextrin derivatives: reversal agents for drug-induced neuromuscular block
WO2002078451A1 (en) * 2001-03-30 2002-10-10 Premier Botanicals Ltd. Pesticidal compositions from prunus
AU2004228011A1 (en) * 2003-04-01 2004-10-21 Memorial Sloan-Kettering Cancer Center Hydroxamic acid compounds and methods of use thereof
JP6898072B2 (ja) * 2015-08-27 2021-07-07 秀行 佐谷 １４−３−３タンパク質活性調節剤
JP7054085B2 (ja) * 2016-06-30 2022-04-13 Ｓｈｉｏｄａライフサイエンス株式会社 バラ科サクラ属に属する植物の葉の抽出液を含有する抗腫瘍剤
JP6541087B1 (ja) * 2018-10-16 2019-07-10 株式会社ワールドナッツ アーモンドペースト組成物
JP7018531B1 (ja) * 2021-04-30 2022-02-10 潤 齋藤 Ａｘｌ阻害剤

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2827452A (en) * 1955-05-31 1958-03-18 Univ Minnesota Stabilization of materials

Also Published As

Publication number Publication date
DE2710327A1 (de) 1977-09-15
DE2710327B2 (de) 1980-04-17
NL172917C (nl) 1983-11-16
FR2343475B1 (en:Method) 1980-04-25
FR2343475A1 (fr) 1977-10-07
DE2710327C3 (de) 1981-02-12
AU2307377A (en) 1978-09-14
NL172917B (nl) 1983-06-16
GB1573965A (en) 1980-08-28
JPS52108027A (en) 1977-09-10
CA1093971A (en) 1981-01-20
NL7702535A (nl) 1977-09-13
BE852283A (fr) 1977-09-09
JPS54962B2 (en:Method) 1979-01-18
US4983636A (en) 1991-01-08

Similar Documents

Publication Publication Date Title
AU509825B2 (en) Isocyanate-prepolymer composition
AU506640B2 (en) APH-indicator composition
AU514934B2 (en) Cosmetic composition
AU516673B2 (en) Rtv-silicone composition
AU514204B2 (en) Pediculicaidal composition
AU518341B2 (en) Insecticide composition
AU499475B2 (en) Anti-malignant tumor composition
AU510212B2 (en) 1-diamino-oxytocin compositions
AU523242B2 (en) Rtv-silicone composition
AU512138B2 (en) Brake-lining composition
AU516060B2 (en) Sterolin compositions
AU510403B2 (en) Sulfolanyl-substituted organosiloxane
AU505082B2 (en) Cosmetic composition
AU510074B2 (en) Coccidiocidal combination
AU514573B2 (en) Compositions
AU507945B2 (en) Deodorant
AU514106B2 (en) Pyridyl-piperazine composition
AU502092B2 (en) Pesticidal composition
AU509271B2 (en) Polyvinylchloride Compositions
AU1545276A (en) Shower-bathtub
AU512477B2 (en) Glass-size composition
SU651768A1 (ru) Состав дл уничтожени моли
AU491992B2 (en) Therapeutic composition
AU2059576A (en) Safety-Closure
AU495935B2 (en) Applicator